SCHEMBL19009982

SCHEMBL19009982

Cc1cc(C(F)(F)F)cc(P(c2ccccc2)c2ccccc2)c1-c1c(C)cc(C(F)(F)F)cc1P(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
CYP3A4 P08684 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
DRD1 P21728 2/20 0.35
KIF11 P52732 2/20 0.34
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
MAPT P10636 1/20 0.33
IL1B P01584 1/20 0.33
TAS2R14 Q9NYV8 2/20 0.33
TACR1 P25103 2/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
P2RX1 P51575 1/20 0.32
IDO1 P14902 1/20 0.32
TDO2 P48775 1/20 0.32
BACE1 P56817 1/20 0.31
RXRG P48443 1/20 0.31
RAPGEF4 Q8WZA2 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12880845 0.91 ALDH1A1 (0.32) ALDH1A1TSHRCYP3A4TDP1DRD1
SCHEMBL4205832 0.83 ALDH1A1 (0.39) ALDH1A1TSHRCYP3A4TDP1DRD1
SCHEMBL1043807 0.79 CYP3A4 (0.39) CYP3A4TDP1DRD1
SCHEMBL301077 0.78 CYP3A4 (0.42) TSHRCYP3A4TDP1DRD1
SCHEMBL31566357 0.78 CYP3A4 (0.42) TSHRCYP3A4TDP1DRD1
SCHEMBL31566348 0.77 HSD11B1 (0.30)
SCHEMBL1043812 0.77 HSD11B1 (0.30)
SCHEMBL7638447 0.75 EDNRB (0.37) ALDH1A1TSHRCYP3A4TDP1KIF11
Hydrochloric Acid SCHEMBL9552697 0.74 CYP3A4 (0.43) ALDH1A1TSHRCYP3A4TDP1KIF11
SCHEMBL16145497 0.74 CYP3A4 (0.52) ALDH1A1TSHRCYP3A4TDP1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173572-A1 CHIRAL LIGAND-BASED METAL-ORGANIC FRAMEWORKS FOR BROAD-SCOPE ASYMMETRIC CATALYSIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173572-A1 CHIRAL LIGAND-BASED METAL-ORGANIC FRAMEWORKS FOR BROAD-SCOPE ASYMMETRIC CATALYSIS POF1B, FGFR1, COASY ALDH1A1 861/4885TSHR 2334/4885CYP3A4 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.